Mosaic ImmunoEngineering Inc.
corporate_fare Company Profile
Mosaic ImmunoEngineering Inc. (OTC:CPMV) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 4 items for CPMV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for CPMV spans 10-Q, 10-K.
Recent high-impact activity:
- Mosaic Q3 10-Q: Cash Down to $151, Going Concern Stands, Liabilities Near $8M
- Mosaic ImmunoEngineering Reports $26 Cash, Reiterates Going Concern
- Mosaic ImmunoEngineering Reports $72 Cash, Reiterates Going Concern, and Confirms Failed Strategic Acquisition
- Mosaic ImmunoEngineering Faces Substantial Doubt on Going Concern, Reports Critical Liquidity Issues and Loss of Key License
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 521 shares in CPMV as of the October 30, 2026 settlement, a 330.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 17, 2026, 100.0% of CPMV volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.